Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma

Abstract Background Individuals with multiple myeloma (MM) receiving immunomodulatory drugs (IMiDs) are at risk of developing venous thromboembolism (VTE), a serious complication. There is no established clinical model for predicting VTE in the Chinese population. We develop a new risk assessment mo...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xiaozhe Li, Xiuli Sun, Baijun Fang, Yun Leng, Fangfang Sun, Yaomei Wang, Qing Wang, Jie Jin, Min Yang, Bing Xu, Zhihong Fang, Lijuan Chen, Zhi Chen, Qimei Yang, Kejie Zhang, Yinhai Ye, Hui Geng, Zhiqiang Sun, Dan Hao, Hongming Huang, Xiaotao Wang, Hongmei Jing, Lan Ma, Xueyi Pan, Wenming Chen, Juan Li
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2023-10-01
coleção:	Thrombosis Journal
Assuntos:	Immunomodulatory drugs Multiple myeloma Risk assessment model Venous thromboembolism Thromboprophylaxis
Acesso em linha:	https://doi.org/10.1186/s12959-023-00534-y
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!